Market Access Views & Analysis | pharmaphorum

Friday 29 November 2024

Channels

Content type

Categories

Categories

Sort by

Order

Views & Analysis

Market Access

Hand arranging wooden cubes in a structure rocket shape. Conceptual of business startup and strategy.

Achieving launch excellence in orphan medicines

New rare disease treatments face a complex market access landscape that presents fundamental challenges for pharmaceutical companies seeking to achieve launch excellence.

Views & Analysis

Optimising market access for biosimilars

Optimising market access for biosimilars

We speak to Sandoz’s global head of biopharmaceuticals, Stefan Hendriks, about the remaining challenges in market access for biosimilars and what the future could hold for this still-bu

Views & Analysis

NICE1

It’s good to talk, NICE says to pharma industry group

NICE has entered into a new dialogue with industry to highlight the benefits of its early scientific advice service.

Views & Analysis

Nine for 2019 Challenges impacting pharma

Nine for 2019: Opportunities for pharma

In the last Nine for 2019 article, we reflected on the major challenges that are sha

Views & Analysis

Nine for 2019 Opportunities for pharma

Nine for 2019: Challenges impacting pharma

As we move close to 2019’s halfway point, it’s time to reflect on the issues that are shaping the pharmaceutical industry for this year and beyond.

Market Access

pharmaphorum podcast bluebird bio Nicola Redfern

Gene therapy and market access: the pharmaphorum podcast

For episode 10 of the pharmaphorum podcast I spoke to Nicola Redfern, who’s general manager at bluebird bio in the UK.